Search - tctmd.com

Displaying 201 - 220 of 287

Sort: Relevancy | Date

News Opinion Editor's Corner TCT 2020

TCT 2020: Short DAPT, Longer TAVR Outcomes, Intravascular Imaging, and More

Shelley Wood

October 09, 2020

News Conference News HFSA 2020

EMBRACE HF: Empagliflozin Cuts PA Pressure in HF With or Without Diabetes

L.A. McKeown

October 09, 2020

News Daily News

VERTIS CV: Ertugliflozin Meets Noninferiority Endpoint but Misses Other Marks

Michael O'Riordan

September 24, 2020

News Daily News

As Interventions Dip During COVID-19, CMS Offers Leniency on Volumes

Todd Neale

September 23, 2020

News Daily News

In MITRA-FR, ‘Disproportionate’ MR Theory Doesn’t Pan Out

Shelley Wood

September 18, 2020

News Daily News

James T. Willerson, Revered Clinician, Editor, and Mentor, Dies at 81

L.A. McKeown

September 18, 2020

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for July 2020

Shelley Wood

July 31, 2020

News Daily News

Too Many HF Trial Results Underreported or Never Published

L.A. McKeown

June 23, 2020

News Conference News TVT 2020

MitraClip Cuts Death, HF Hospitalization Across NYHA Class: COAPT

Michael O'Riordan

June 21, 2020

News Opinion Editor's Corner

A ‘Virtual’ ACC 2020? TCTMD Has You Covered, However Things Roll Out

Shelley Wood

March 16, 2020

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for February 2020

Shelley Wood

March 02, 2020

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for January 2020

Shelley Wood

January 31, 2020

News Daily News

Most Secondary Prevention Patients Are Eligible for Multiple Drugs

Michael O'Riordan

January 03, 2020

News Opinion Editor's Corner

The Biggest News of 2019: TCTMD’s Top 10

Shelley Wood

January 01, 2020

News Conference News AHA 2019

Dapagliflozin Has Benefits Across Heart Failure Subgroups

Todd Neale

November 17, 2019

News Conference News AHA 2019

AHA 2019: Beyond ISCHEMIA Are Plenty of Coronary, Structural, and HF Trials

Shelley Wood

November 11, 2019

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for October 2019

Todd Neale

October 31, 2019

News Opinion Editor's Corner TCT 2019

TCT 2019 Day Three: Thowback Saturday Revisits COAPT, PARTNER 2A, and EXCEL

Shelley Wood

September 28, 2019

Presentation TCT 2019

Defining High Bleeding Risk: HBR ARC

Presenter: Philip Urban

September 27, 2019

Presentation TCT 2019

Reimbursement Pathways for Shock Devices

Presenter: Lori Ashby

September 27, 2019

Advertisement

TCT 2020: Short DAPT, Longer TAVR Outcomes, Intravascular Imaging, and More

EMBRACE HF: Empagliflozin Cuts PA Pressure in HF With or Without Diabetes

VERTIS CV: Ertugliflozin Meets Noninferiority Endpoint but Misses Other Marks

As Interventions Dip During COVID-19, CMS Offers Leniency on Volumes

In MITRA-FR, ‘Disproportionate’ MR Theory Doesn’t Pan Out

James T. Willerson, Revered Clinician, Editor, and Mentor, Dies at 81

TCTMD’s Top 10 Most Popular Stories for July 2020

Too Many HF Trial Results Underreported or Never Published

MitraClip Cuts Death, HF Hospitalization Across NYHA Class: COAPT

A ‘Virtual’ ACC 2020? TCTMD Has You Covered, However Things Roll Out

TCTMD’s Top 10 Most Popular Stories for February 2020

TCTMD’s Top 10 Most Popular Stories for January 2020

Most Secondary Prevention Patients Are Eligible for Multiple Drugs

The Biggest News of 2019: TCTMD’s Top 10

Dapagliflozin Has Benefits Across Heart Failure Subgroups

AHA 2019: Beyond ISCHEMIA Are Plenty of Coronary, Structural, and HF Trials

TCTMD’s Top 10 Most Popular Stories for October 2019

TCT 2019 Day Three: Thowback Saturday Revisits COAPT, PARTNER 2A, and EXCEL

Defining High Bleeding Risk: HBR ARC

Reimbursement Pathways for Shock Devices

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content